TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE

Transfusion-associated graft-versus-host disease (TA-GvHD) is a very rare but potentially lethal complication occurring after blood components transfusion. Goal of the article: to analyze the literature describing this complication. TA-GvHD can develop due to several factors: quantity and viability of lymphocytes, contained in the transfused blood component, responsiveness of the patient's immune system to replantation of donor lymphocytes and degree of immunological HLA-homology between the donor and the recipient. History and epidemiology of this fatal syndrome, its pathogenesis, clinical manifestations, diagnostics and therapy have been reviewed. It has been shown that the main prevention techniques include abstaining from blood components transfusion collected from close relatives and using special irradiation modes, suppressing proliferation of the donor's lymphocytes. Conclusion: Doctors performing blood components transfusion should note that post-transfusion reaction development in the variant of graft-versus-host might develop in order to provide timely diagnostics and to start the specific treatment of this complication.

1. Krivolapova А.Yu., Belousova I.E., Smirnova I.O. et al. Pathomorphological diagnostics of cutaneous manifestations of graft-versus-host disease. Arkhiv Patologii, 2014, vol. 76, no. 4, pp. 24-28. (In Russ.)

2. Agbaht K., Altintas N. D., Topeli A. et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature. Transfusion, 2007, vol. 47, no. 8, pp. 1405-1411.

3. Aoki Y., Nakamura H., Sakakibara Y. Probable graft-versus-host reaction following massive blood transfusion in an aged patient with postoperative aortic aneurysm: a case report. (Article in Japanese). Nihon Naika Gakkai Zasshi, 1984, vol. 73, no. 8, pp. 1209-1216.

4. Appleton A.L., Sviland L., Pearson A.D. et al. Diagnostic features of transfusion associated graft versus host disease. J. Clin. Pathol., 1994, vol. 47, pp. 541-546.

5. Asai T., Inaba S., Ohto H. et al. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vshost disease in Japan. Transfusion Med., 2000, vol. 10, pp. 312-320.

6. Aso T., Asano Y., Harada M. et al. Fatal graft-versus-host disease following transfusion during open heart surgery. Nihon Ketsueki Gakkai Zasshi, 1989, vol. 52, no. 6, pp. 1064-1071.

7. Benson K., Marks A.R., Marshall M.J., Goldstein J.D. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors. Transfusion, 1994, vol. 34, pp. 432-437.

8. Billingham R.E., Brent L.A simple method for inducing tolerance of skin homografts in mice. Transplant Bull., 1957, vol. 4, no. 2, pp. 67-71.

9. Billingham R.E., Brent L. Quantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease. Phil Trans. R. Soc. Biol., Sci. 1959, vol. 242, pp. 439-477.

10. Boparai J.K., Singh S. Hemovigilance: A new beginning in India. Int. J. Appl. Basic Med. Res., 2015, vol. 5, no. 3, pp. 200-202.

11. Button L.N., DeWolf W.C., Newburger P.E. et al., The effects of irradiation on blood components. Transfusion, 1981, vol. 21, pp. 419-426.

12. Carey P.M., Sacher R.A. Transfusion-associated graft versus host disease. In: Simon T.L., Dzik W.H., Synder E.L. et al. eds. Rossi’s principles of transfusion medicine. Philadelphia: Lippincott Williams & Wilkins. 2002, pp. 852–864.

13. Chang H., Voralia M., Bali M. et al. Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood. Br. J. Haematol., 2000, vol. 111, no. 1, pp. 146-156.

14. Davey R.J., McCoy N.C., Yu M. et al. The effect of prestorage irradiation on posttransfusion red cell survival. Transfusion, 1992, vol. 32, pp. 525-528.

15. Dwyre D., Holland P. Review: transfusion-associated graft-versus-host disease. Vox Sang., 2008, vol. 95, pp. 85-93.

16. Fast L.D., Nevola M., Tavares J. et al. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion, 2013, vol. 53, no. 2, pp. 373-381.

17. Heim M.U., Munker R., Sauer H. et al. Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates. Beitr Infusionsther, 1992, vol. 30, pp. 178-181.

18. Heymer B. Histopathological Manifestations of Acute Gvhd; in Clinical and Diagnostic Pathology of Graft-Versus-Host-Disease. Berlin, Germany, Springer, 2002 21 Sohi I.

19. Hong R., Gatti R. A., Good R.A. Hazards and potential benefits of blood-transfusion in immunological deficiency. Lancet, 1968, vol. 2(7564), pp. 388-389.

20. Hutchinson K., Kopko P.M., Muto K.N. et al. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion, 2002, vol. 42, no. 12, pp. 1567-1572.

21. Ito K., Yoshida H., Yanagibashi K. et al. Change of HLA phenotype in postoperative erythroderma. Lancet, 1988, vol. 1(8582), pp. 413-414.

22. Juji T., Takahashi K., Shibata Y. et al. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. N. Engl. J. Med., 1989, vol. 321(1), pp. 56.

23. Kilic S., Kavurt S., Adim B.S. Transfusion-associated graft-versus-host disease in severe combined immunodeficiency. J. Investig Allergol. Clin. Immunol., 2010, vol. 20, no. 2, pp. 153-156.

24. Klein H.G. Transfusion-associated graft-versus-host disease: less fresh blood and more gray (Gy) for an aging population. Transfusion, 2006, vol. 46, pp. 878-880.

25. Kopolovic I., Ostro J., Tsubota H. et al. A systematic review of transfusion-associated graft-versus-host disease. Blood, 2015, vol. 126, pp. 3.

26. Kunstmann E., Bocker T., Roewer L. et al. Diagnosis of transfusion-associated graftversus-host disease by genetic fingerprinting and polymerase chain reaction. Transfusion, 1992, vol. 32, pp. 766-770.

27. Lee T.H., Donegan E., Slichter S. et al. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood, 1995, vol. 85, pp. 1207-1214.

28. Markey K.A., MacDonald K.P., Hill G.R. The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood, 2014, vol. 124, no. 3, pp. 354-362.

29. Matsushita H., Shibata Y., Fuse K. et al. Sex chromatin analysis of lymphocytes invading host organs in transfusion-associated graft-versus-host disease. Virchows Arch, B Cell Pathol. Incl. Mol. Pathol., 1988, vol. 55, no. 4, pp. 237-239.

30. Murphy J.B. The effect of adult chicken organ graft on the chick embryo. J. Exp. Med., 1916, vol. 24, pp. 1-6.

31. Naiman J.L., Punnett Н.Н., Lischner H.W. et al. Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis. N. Engl. J. Med., 1969, vol. 281, pp. 697-701.

32. Nishimura M., Akaza T., Tadokoro K. et al. Possible involvement of donor-derived B cells in development of post-transfusion graft-versus-host disease (Article in Japanese). Nihon Rinsho, 1997, vol. 55, no. 9, pp. 2246-2251.

33. Ohto H., Anderson K.C. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfusion Med. Rev., 1996, vol. 10, pp. 31-43.

34. Park B.H., Good R.A., Gate J., Burke B. Fatal graft-versus-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease. Transplant Proc., 1974, vol. 6, pp. 385-387.

35. Pelszynski M.M., Moroff G., Luban N.L. et al. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versushost disease. Blood, 1994, vol. 83, pp. 1683-1689.

36. Ramirez A.M., Woodfield D.G., Scott R., McLachlan J. High potassium levels in stored irradiated blood. Transfusion, 1987, vol. 27, pp. 444-445.

37. Sakakibara T., Juji T. Post-transfusion graft-versus-host disease after open heart surgery. Lancet, 1986, vol. 2(8515), pp. 1099.

38. Sazama K., Holland P.V. Transfusion-induced graft-versus-host disease. In: Garratty G, editor. Immunobiology Transf. Med. New York, NY, Marcel Dekker, 1993.

39. Schroeder M.L. Transfusion-associated graft-versus-host disease.Br. J. Haematol., 2002, vol. 117(2):275-87

40. Shimoda T. On postoperative erythroderma (In Japanese). Geka., 1955, vol. 17, pp. 487–492.

41. Shivdasani R.A., Haluska F.G., Dock N.L. et al. Graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N. Engl. J. Med., 1993, vol. 328, pp. 766-770.

42. Simonsen M. The impact on the developing embryo and newborn animal of adult homologous cells. Acta Pathol Microbiol Scand., 1957, vol. 40, no. 6, pp. 480-500.

43. Takahashi K., Juji T., Miyamoto M. et al. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group. Lancet, 1994, vol. 343, no. 8899, pp. 700-702.

44. Terasaki P.I. Identification of the type of blood-cell responsible for the graft-versus-host reaction in chicks. J. Embryol. exp. Morph., 1959, vol. 7, part 3. pp. 394-408.

45. Treleaven J., Gennery A., Marsh J. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Jim Thurston1 and David Webb Brit. J. Haematology, 2010, vol. 152, pp. 35-51.

46. Uchida S., Wang L., Yahagi Y., et al. Utility of fingernail DNA for evaluation of chimerism after bone marrow transplantation and for diagnostic testing for transfusion-associated graft-versus-host disease. Blood, 1996, vol. 87, pp. 4015-4016.

47. Utter G.H., Reed W.F., Lee T.H., Busch M.P. Transfusion-associated microchimerism. Vox Sang., 2007, vol. 93, pp. 188-195.

48. van der Meer P.F., Pietersz R.N. Gamma irradiation does not affect 7-day storage of platelet concentrates. Vox Sanguinis, 2005, vol. 89, pp. 97-99.

49. Wagner F.F., Flegel W.A. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion, 1995, vol. 35, no. 4, pp. 284-291.

50. Wang L., Juji T., Tokunaga K. et al. Polymorphic microsatellite markers for the diagnosis of graft-versus-host disease. N. Engl. J. Med., 1994, vol. 330, pp. 398-401.